January 03, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today issued a response to a PixarBio Corporation press release dated January 3, 2017. The press release claimed that PixarBio had made a $77,000,000 stock offer to acquire InVivo. InVivo Therapeutics Corporation was not privy to the announcement made today and […]